Showing 991-1000 of 1057 results for "".
- Secondary Prevention Lags for Individuals who Experienced Strokehttps://practicalneurology.com/news/secondary-prevention-lags-for-individuals-who-experienced-stroke/2469262/In a study presented at the American Heart Association's Quality of Care & Outcomes Research Scientific Sessions 2020 (held virtually) individuals who experienced stroke were less likely to receive preventive care for atherosclerotic cardiovascular disease compared with those who had peri
- Long-Term Exposure to Air Pollution and Rate of Cognitive Declinehttps://practicalneurology.com/news/long-term-exposure-to-air-pollution-and-rate-of-cognitive-decline/2469226/In a study published in Neurology researchers found an association of air pollution levels with cognitive impairment and decline in 1 of 2 large groups but not both. Both groups were ethnically and racially diverse and lived in the Northern Manhattan area of New York City. Participant's resid
- FDA Accepts Supplemental NDA for Cannabidiol to Treat Seizures of Tuberous Sclerosis Complexhttps://practicalneurology.com/news/fda-accepts-supplemental-nda-for-cannabidiol-to-treat-seizures-of-tuberous-sclerosis-complex/2469212/The US Food and Drug Administration (FDA) has accepted for filing, with priority review, a recently submitted supplemental new drug application (sNDA) for the use of cannabidiol (Epidiolex, GW Pharmaceuticals, Carlsbad, CA) CV to treat seizures associated with tuberous sclerosis complex (TSC). Th
- AHA Promotes Secondary Stroke Prevention as Crucial During COVID-19 Pandemichttps://practicalneurology.com/news/aha-promotes-secondary-stroke-prevention-as-crucial-during-covid-19-pandemic/2469197/As hospitals, healthcare systems, and healthcare providers strive to reduce the spread of coronavirus, the American Heart Association (AHA) offers tips for heart attack and stroke survivors for secondary prevention during this difficult time. Based on current information about the
- Recombinant Factor Xa for Anticoagulant Reversal Lowers Mortality Rateshttps://practicalneurology.com/news/recombinant-factor-xa-for-anticoagulant-reversal-lowers-mortality-rates/2469191/New data reinforces the value of recombinant factor Xa (Andexxa, Portola Pharmaceuticals, South San Francisco, CA). Use of recombinant factor Xa to reverse anticoagulation with rivaroxaban, apixaban, or warfarin was associated with a lower rate of in-hospital and 30-day mortality compared with 4-
- Daylights Saving and the Coronavirus Causing a Significant Impact on Sleephttps://practicalneurology.com/news/daylights-saving-and-the-coronavirus-causing-a-significant-impact-on-sleep/2469183/Lack of sleep from daylight savings time affects productivity, work performance, concentration, and memory, according to physicians at the University of Washington. The coronavirus may further affect sleep with the ongoing fear and uncertainty associated with this rapidly evolving situation. 
- Alzheimer Diagnoses Increase Significantly in Adults from 2013-2017https://practicalneurology.com/news/alzheimer-diagnoses-increase-significantly-in-adults-from-2013-2017/2469175/The number of Americans diagnosed with early-onset dementia or Alzheimer disease (AD) increased by 200% from 2013 to 2017. The average age of a person living with either form of dementia is 49. The findings came from a new Blue Cross Blue Shield Association (BCBSA) report, "Early-Onset Demen
- Expanded Indication, Tuberous Sclerosis, Sought for Cannabidiol Seizure Treatmenthttps://practicalneurology.com/news/expanded-indication-tuberous-sclerosis-sought-for-cannabidiol-seizure-treatment/2469148/A supplemental new drug application (sNDA) was submitted to the Food and Drug Administration (FDA) for cannabidiol (Epidiolex, GW Pharmaceuticals, Carlsbad, CA). The sNDA seeks to expand the cannabidiol label to include the treatment of seizures associated with tuberous sclerosis complex (TSC), a
- New Category 3 CPT Code for Eye-Tracking Test for Concussion Diagnosishttps://practicalneurology.com/news/new-category-3-cpt-code-for-eye-tracking-test-for-concussion-diagnosis/2469064/The American Medical Association (AMA) has confirmed the addition of a new code for an eye-tracking diagnostic procedure for concussion (Eyebox; Oculogica, New York, New York).The category 3 CPT Code, 0X17T, eye movement analysis test without spatial calibration,allows clinicians to appropriately
- Continued Promise for BAN2401—An Anti-Amyloid β Protofibril Antibodyhttps://practicalneurology.com/news/continued-promise-for-ban2401an-anti-amyloid-b-protofibril-antibody/2468972/In multiple presentations at the Alzheimer’s Association International Conference in Los Angeles, July 14-18, 2019, data suggest continued promise of BAN2401 (Eisai, Woodcliff Lake, NJ) for treatment of Alzheimer’s disease. Because of safety concerns for APOE4 carriers